Table 1 Clinical, laboratory, and ultrasonographic characteristics of the model design cohort
From: Development and validation of a model for early diagnosis of biliary atresia
Characteristics | BA (n = 52) | Non-BA (n = 96) | P value |
|---|---|---|---|
Age (days) | 48 ± 10 | 44 ± 11 | 0.02 |
Male sex (%) | 24(46.2) | 53(55.2) | 0.31 |
Clay-like stool (%) | 10(43.5) | 7(13.2) | < 0.01 |
ALT(U/L) | 173.7 ± 112.2 | 165.8 ± 155.6 | 0.78 |
AST(U/L) | 284.2 ± 163.8 | 244.0 ± 212.8 | 0.28 |
TBIL (µmol/L), median (IQR) | 165(130,200) | 159(80.5,211) | 0.06 |
DBIL (µmol/L), median (IQR) | 116(95.5,154) | 97(32.5,149.5) | 0.01 |
DBIL/TBIL (%), median (IQR) | 74.6(67.7,82.6) | 66.9(54.4,78.2) | < 0.01 |
γGT (U/L), median (IQR) | 447(206,822) | 165(104,319) | < 0.01 |
LDH (U/L),median (IQR) | 410(322.5,649) | 485(336.5,809) | 0.15 |
ALP (U/L) | 616.7 ± 248.1 | 501.6 ± 275.9 | 0.07 |
TBA (µmol/L) | 157.1 ± 63.0 | 124.1 ± 70.5 | 0.17 |
Hepatomegaly (%) | 2(10.5) | 5(8.6) | 0.80 |
Abnormal gallbladder (%) | 34(91.9) | 2(2.8) | < 0.01 |
TC sign positive (%) | 30(81.1) | 12(20.7) | < 0.01 |